Financial Daily from THE HINDU group of publications
Thursday, March 18, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

CORPORATE

RESEARCH & DEVELOPMENT
Dr Reddy's diabetes drug to enter phase-III trials soon
BALAGLITAZONE, the diabetes molecule of Dr Reddy's Labs is slated to enter the phase-III trials (human trials) soon. The company had out-licensed this compound to the global drug major Novo Nordisk in March 1997. The development is being ... More

ANNOUNCEMENTS
Tata Honeywell to provide security solutions to IOC
INDIAN Oil Corporation today decided to take the integrated security solution provided by the Pune-based Tata Honeywell Ltd (THL), for a robust and future-wise security system. THL is a provider of automation and software solutions. According ... More

INFORMATION TECHNOLOGY
Indian cos lack focus on Web strategy: Survey
A SURVEY conducted by ValueNotes Database to gauge Web site effectiveness strategies employed by Indian companies has noted that most Indian companies lack a "focused strategy for online presence" with 72 per cent of senior management interviewed ... More

CORPORATE BONDS
Fitch gives high rating for L&T Holding's NCD programme
FITCH India has assigned F1+(ind) rating to the proposed Rs 75-crore short-term non-convertible debenture programme of L&T Holdings Ltd (LTHL), rating being based on the `letter of comfort' provided by L&T Ltd. This is apart from the propose More

HMT seeks Govt nod for Rs 300-cr bonds issue
HMT Ltd has sought the Government nod to sell Rs 300 crore of bonds in the near time to retire part of its high-cost debt, according to company sources. HMT currently has close to Rs 400-crore high-cost debts on its books and it expects to ... More

MERGERS & ACQUISITIONS
GSK, Burroughs Wellcome boards clear merger — Share swap at 14:10
THE long-drawn merger of Burroughs Wellcome India Ltd (BWIL) into GlaxoSmithKline Pharmaceuticals Ltd (GSK) in India was sealed on Wednesday with the boards of both the companies approving the scheme of amalgamation. The boards have decided on ... More

Merger with Burroughs: Swap ratio favours Glaxo shareholders
THE completion of the legal merger between GlaxoSmithKline Pharmaceuticals and Burroughs Wellcome - nine years after the merger at the global level - is significant as it ends uncertainty and periodic speculation on this score. During ... More

ALLIANCES & JOINT VENTURES
Two-wheeler loans for farmers: Bajaj Auto ties up with Andhra Bank
THE two-wheeler major Bajaj Auto Ltd (BAL) has entered into an alliance with Andhra Bank for extending two-wheeler loans to the farming community across the country with special concessions to the customers under the scheme called `Bajaj Kisan ... More

STANDARDS & BENCHMARKS
Club Mahindra gets ISO 9001:2000
CLUB Mahindra Holidays (CMH), the lifetime holiday company, has received the ISO 9001:2000 certification for its property at Lakeview Munnar, demonstrating its commitment to quality management. According to an official statement, Club Mahindra ... More

SICK UNITS
Shree Synthetics fate hinges on capital infusion, revival package
IN lieu of a Calcutta High Court order, the management of the ailing Shree Synthetics Ltd has reduced its capital base by 80 per cent and has also merged an investment firm into itself. Now, the fate of the company, which is a producer of ... More


Scoreboard
SE Diary



Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line

Pick a Winner Stock Market Contest

Top Stories
Heatwave threatens wheat crop


Merger with Burroughs: Swap ratio favours Glaxo shareholders

Polaris fine-tunes strategy — Hyderabad centre to focus on treasury, securitisation

`Chit funds stunted by stiff regulations'

Banks move high coupon SLR bonds to HTM

Tyre cos cry foul over Chinese imports

Organised funding edges up in Hindi films

Looking back
Mar. 7-Mar. 13
IOC to take a hit as crude prices soar

`Royal Enfield has an iconic status'

Cairn strikes more oil in Rajasthan

Spic close to gas supply pact for Dubai project

Patent cases againt Dr Reddy's, Ranbaxy — `Pfizer's victory not to impact Indian generics'


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line